搜索

159-2642-3062

服务热线(工作日:9:00-17:30)

武汉科斯坦生物科技有限公司

热搜词:燕窝酸,不饱和脂肪酸,神经酰胺,花青素,黄酮,皂苷

Wuhan Chemstan Biotechnology Co., Ltd.

武汉科斯坦生物科技有限公司

代谢组学

科研服务

抗体/蛋白

地       址:武汉市东湖新技术开发区高新大道666号,武汉

                 国家生物产业基地B、C、D区研发楼C1栋
产品销售:15926423062
技术服务:18971263062                                             
E - mail :
info@chemstan.com       
邮       编:430075

化合物单体

科斯坦生物(Chemstan)所有产品和服务仅用于科学研究,不为任何个人或者非科研性质的用途提供产品和服务。

Copyright @ 武汉科斯坦生物科技有限公司.All rights reserved

网站建设:中企动力武汉鄂ICP备19006850号-1

浏览量:
产品名称:

Canakinumab ELISA Kit

NO.
79
货号:
CSB95601
中文名称
Canakinumab ELISA Kit
英文名词
Canakinumab ELISA Kit
CAS号
914613-48-2
产品货号:
CSB95601
货期:
现货
价格与订购:
6768.00
数量
-
+
库存:
5
没有此类产品
产品信息
如何订购
Catalog No.icon
CSB95601
Stability and Storageicon
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Detection methodicon
Colorimetric
Precisionicon
CV<20%
Sample typeicon
Plasma, Serum
Assay typeicon
Quantitative
Sensitivity
icon
0.156 μg/ml
Range
icon
0.31-5 μg/mL
Recoveryicon
80-120%
Specificationsicon
Canakinumab
Alternative Namesicon
ACZ885, CAS: 914613-48-2
Backgroundicon
Canakinumab (ACZ885, Ilaris) is a human anti-IL-1β monoclonal antibody developed by Novartis. its mode of action is based on the neutralization of 1β signaling, resulting in suppression of inflammation in patients with disorders of autoimmune origin. In June 2009 the drug was approved by the US Food and Drug Administration for the treatment of familial cold auto-inflammatory syndrome and Muckle-wells syndrome, which are inflammatory diseases related to cryopyrin-associated periodic syndromes. The drug is currently being evaluated for its potential in the treatment of rheumatoid arthritis, systemic-onset juvenile idiopathic arthritis, chronic obstructive pulmonary disease, type 1 and 2 diabetes and ocular diseases. Reports from clinical trials suggest that canakinumab is well-tolerated in most patients, and no serious adverse effects have been reported. The drug provides significant advantages over existing competitive therapies, including bimonthly administration and approved use in children.
Shippingicon
2-8 ℃
Noteicon
For Research Use Only.
未找到相应参数组,请于后台属性模板中添加
暂未实现,敬请期待
暂未实现,敬请期待
上一篇
下一篇